SNCR 53.76 Synchronoss Technologies $SNCR Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
SNCR 53.76 Synchronoss Technologies $SNCR Hit a 52 week high of 54.05 Currently at 53.76 +0.09 +0.17% With a day low of 53.16 and a total volume of 36,386.

SNCR Synchronoss Technologies Recent Headline News

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Synchronoss Technologies Is Up 0.3% (SNCR)
Comtex SmarTrend(R) - Mon Nov 10, 12:55PM CST
13 days ago, on October 28th, 2014, Synchronoss Technologies (NASDAQ:SNCR) reported its earnings. Analysts, on average, expected earnings of $0.43 per share on sales of $119.2 million. Synchronoss Technologies actually reported earnings of $0.46 per share on sales of $125.2 million, beating EPS estimates by $0.03 and beating revenue estimates by $6.0 million. Since the company's report, shares of Synchronoss Technologies have risen from $51.95 to $52.12, representing a gain of 0.3% in the past 13 days.
SNCR: 52.97 (-0.70)

61.6% Return Seen to Date on SmarTrend Synchronoss Technologies Call (SNCR)
Comtex SmarTrend(R) - Mon Nov 10, 12:23PM CST
SmarTrend identified an Uptrend for Synchronoss Technologies (NASDAQ:SNCR) on June 10th, 2014 at $32.31. In approximately 5 months, Synchronoss Technologies has returned 61.56% as of today's recent price of $52.20.
SNCR: 52.97 (-0.70)

Insider Trading Alert - SAVE, SNCR And OII Traded By Insiders
at The Street - Mon Nov 10, 10:45AM CST
Stocks with insider trader activity include SAVE, SNCR and OII
SAVE: 78.70 (-0.35), OII: 70.83 (+1.10), SNCR: 52.97 (-0.70)

Synchronoss Technologies to Present at the 2014 Wells Fargo Technology, Media and Telecom Conference
Business Wire - Thu Nov 06, 3:07PM CST
Synchronoss Technologies, Inc. (NASDAQ: SNCR), the mobile innovation leader that provides cloud solutions and software-based activation for connected devices across the globe, today announced that its Chief Financial Officer, Executive Vice President & Treasurer, Karen Rosenberger; and its Executive Vice President & Chief Innovation Officer, David Berry, will present at the 2014 Wells Fargo Technology, Media and Telecom Conference being held at The Waldorf Astoria in New York City on Wednesday, November 12, 2014 at 11:20 a.m. Eastern Time.
SNCR: 52.97 (-0.70), WFC: 53.66 (-0.17)

Update: Synchronoss Q3 Earnings
ONeil Trader - at Seeking Alpha - Tue Nov 04, 2:20PM CST

SNCR: 52.97 (-0.70)

Synchronoss Technologies Shares Up 59.2% Since SmarTrend's Buy Recommendation (SNCR)
Comtex SmarTrend(R) - Mon Nov 03, 9:32AM CST
SmarTrend identified an Uptrend for Synchronoss Technologies (NASDAQ:SNCR) on June 10th, 2014 at $32.31. In approximately 5 months, Synchronoss Technologies has returned 59.24% as of today's recent price of $51.45.
SNCR: 52.97 (-0.70)

Insider Trading Alert - SAVE, SNCR And AJG Traded By Insiders
at The Street - Fri Oct 31, 9:30AM CDT
Stocks with insider trader activity include SAVE, SNCR and AJG
SAVE: 78.70 (-0.35), SNCR: 52.97 (-0.70), AJG: 48.09 (-0.17)

Synchronoss Technologies Q3 2014 revenue up year-over-year
M2 - Wed Oct 29, 7:37AM CDT
Synchronoss Technologies, Inc. (NASDAQ: SNCR) said that on a GAAP basis, it reported net revenues of USD125.2 million, representing an increase of 40 percent compared to the third quarter of 2013.
SNCR: 52.97 (-0.70)

Chipotle And Apple Suppliers Rise Among 5 Young Guns
at Investor's Business Daily - Wed Oct 29, 7:02AM CDT
Youth has its advantages. Young companies often come out of the gate strong, and strong growth keeps them looking young. Today's Young Guns Screen of the Day features hot picks that have gone public in the last 15 years. In particular, the stocks...
SNCR: 52.97 (-0.70), FB: 74.40 (-0.60), CMG: 653.94 (+5.08), ILMN: 187.90 (-0.37), NXPI: 73.97 (-0.42), AAPL: 109.15 (+0.32), AVGO: 86.15 (+0.24)

Downgrade Alert for Synchronoss Technologies (SNCR)
Comtex SmarTrend(R) - Wed Oct 29, 6:52AM CDT
Synchronoss Technologies (NASDAQ:SNCR) was downgraded from Strong Buy to Outperform at Raymond James today. The stock closed yesterday at $51.95 on volume of 2.0 million shares, above average daily volume of 489,000. Synchronoss Technologies, Inc. provides e-commerce transaction management solutions to the communications services marketplace.
SNCR: 52.97 (-0.70)

Synchronoss Technologies' (SNCR) CEO Stephen Waldis on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Oct 28, 1:02PM CDT

SNCR: 52.97 (-0.70)

Stocks Hang Near Day's Highs; Twitter Cuts Losses
at Investor's Business Daily - Tue Oct 28, 12:33PM CDT
Stocks held near their session highs Tuesday afternoon amid another flurry of earnings reports and mixed economic data. Led by gains in solar and security software stocks, the Nasdaq rose 1%. The S&P 500 was up 0.5%. Earlier, the benchmark index...
YHOO: 48.91 (-0.50), VDSI: 27.21 (-1.06), SNCR: 52.97 (-0.70), TWTR: 39.52 (-0.07)

Synchronoss Technologies Cloud Growth Fuels Q3 Beat
at Investor's Business Daily - Tue Oct 28, 9:47AM CDT
Synchronoss Technologies (SNCR) continues to find success in the cloud. The enterprise software company reported third-quarter earnings early Tuesday that soundly beat analyst estimates as the company's cloud service business grew more than 115% vs....
T: 35.03 (-0.09), SNCR: 52.97 (-0.70), VZ: 50.45 (-0.27), AAPL: 109.15 (+0.32)

Synchronoss Technologies (SNCR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Oct 28, 7:25AM CDT

SNCR: 52.97 (-0.70)

Synchronoss tops Street 3Q forecasts
Automated Insights - Tue Oct 28, 7:15AM CDT
BRIDGEWATER, N.J. (AP) _ Synchronoss Technologies Inc. (SNCR) on Tuesday reported earnings of $9.3 million in its third quarter.
SNCR: 52.97 (-0.70)

Synchronoss Technologies beats by $0.03
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 7:04AM CDT

SNCR: 52.97 (-0.70)

Synchronoss Technologies, Inc. Announces Third Quarter 2014 Financial Results
Business Wire - Tue Oct 28, 7:03AM CDT
--Cloud Services non-GAAP revenue of $57.9 million increases 115% year-over-year
SNCR: 52.97 (-0.70)

Synchronoss Technologies Has Returned 43.9% Since SmarTrend Recommendation (SNCR)
Comtex SmarTrend(R) - Mon Oct 27, 9:10AM CDT
SmarTrend identified an Uptrend for Synchronoss Technologies (NASDAQ:SNCR) on June 10th, 2014 at $32.31. In approximately 5 months, Synchronoss Technologies has returned 43.95% as of today's recent price of $46.51.
SNCR: 52.97 (-0.70)

Stocks Flat In Mixed Volume; Amazon.com Weighs On Techs
at Investor's Business Daily - Fri Oct 24, 9:52AM CDT
Stocks wobbled in and out of narrow gains early Friday. The Nasdaq, S&P 500 and Dow Jones industrials nibbled at 0.1% gains, but were tipping in and out of mixed trade. Nasdaq volume rose 38%. Trade on the NYSE was 13% below levels at the same time...
AMZN: 311.24 (+6.13), F: 14.36 (+0.36), SNCR: 52.97 (-0.70), GILD: 108.50 (+1.48), JAZZ: 171.66 (-2.77), ALTR: 35.08 (-0.11), BMY: 58.72 (-0.09), PG: 89.60 (+0.15), KLAC: 80.18 (-0.33), MSFT: 48.79 (-0.10), UPS: 108.55 (-0.50)

Facebook Among 10 IBD 50 Stocks With Rising Estimates
at Investor's Business Daily - Thu Oct 23, 9:43PM CDT
Facebook (FB) has been on a huge roll. But even with more than a billion users worldwide, the social networking giant wants more. CEO and founder Mark Zuckerberg stunned Chinese university students on Wednesday with a half-hour discussion in...
SNCR: 52.97 (-0.70), AKRX: 35.24 (-0.92), FB: 74.40 (-0.60), JAZZ: 171.66 (-2.77), ILMN: 187.90 (-0.37), NXPI: 73.97 (-0.42), TWTR: 39.52 (-0.07), AAPL: 109.15 (+0.32), BITA: 79.28 (-2.80), AVGO: 86.15 (+0.24), ADS: 283.20 (-1.79)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 158

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Jeff McLean Takes the Helm as ghSMART's New CEO

Updated Category News Views 620

Jeff McLean Takes the Helm as ghSMART's New CEO G.H. Smart & Company, LLC, the leading firm in leadership advisory, proudly announces the appointment of Jeff McLean as the Chief Executive Officer. McLean, who has been serving as President of ghSMART for three years, will now guide the firm towards its next exciting phase of growth and innovation. Achievements Under...

Continue Reading
Growth Forecast for Hot Dog and Sausage Market to 2032

Updated Category News Views 51

Introduction to the Hot Dog and Sausage Market The global market for hot dogs and sausages is witnessing a remarkable upward trajectory, with projections estimating it will reach USD 112.41 billion by 2032. This growth is fueled by a compound annual growth rate (CAGR) of 3.50%. The factors contributing to this expansion are numerous, including shifting consumer...

Continue Reading
Exro Technologies Adjusts Leadership with New CEO Plans

Updated Category News Views 337

Exro Technologies Announces Leadership Changes Exro Technologies Inc. has made a significant announcement regarding its leadership structure. Following the resignation of Sue Ozdemir from her role as Chief Executive Officer, the company has initiated steps to ensure a seamless transition and continuity in leadership. New Chief Restructuring Officer Appointed Introduction...

Continue Reading
Hillenbrand Increases Quarterly Dividend to $0.225 Per Share

Updated Category News Views 208

Hillenbrand's Exciting Dividend Announcement The board of directors of Hillenbrand, Inc. (NYSE: HI) has proudly announced a regular cash dividend of $0.225 per share on its common stock. This announcement signifies an annual increase of $0.01, bringing the total dividend rate to $0.90 per share for fiscal 2025. Such a commitment underlines Hillenbrand's dedication to...

Continue Reading
Trump's World Liberty Financial Token Sale Raises $220 Million

Updated Category News Views 113

Trump's World Liberty Financial Token Sale Demonstrates Huge Demand The World Liberty Financial project, closely associated with Donald Trump, made headlines recently as its token sale reached an impressive $220 million in just the first hour. Despite facing multiple outages on its website, the initiative showcased remarkable demand and interest. Details of the Token Sale...

Continue Reading